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The purpose of the present study was to examine at
autopsy the effect of multiple defibrillations on the myo-
cardium and the pathologic consequences of short- and
long-term placement of the intravascular and lnterperl-
cardial leads of the automatic implantable cardioverter-
defibrillator. Twenty-five patients were examined at au-
topsy; 8 of them underwent lead implantation only and
17 received both leads and the automatic implantable
cardioverter-defibrillator. Twelve patients (48%) died of
ventricular tachycardia or ventricular fibrillation; seven
(28%) died of other causes.
Acute pericarditis occurred in all patients, resulting
in a localized, progressive fibrosis around the apical patch
lead without giving rise to pericardial restriction.
Thrombus formation was associated with the superior
vena cava spring electrode in four patients (17%) and
the right ventricular rate-sensing electrode in one patient
(4%). Asymptomatic pulmonary emboli occurred in two
patients (8%). In one patient who underwent defibril-
The automatic implantable cardioverter-defibrillator is an
electronic device capable of detecting and treating ventric-
ular tachycardia and ventricular fibrillation. The device and
its lead system have been described elsewhere (1-3). Al-
though improved survival from ventricular tacharrhythmias
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lation 59 times, superior vena cava changes consisted of
vein wall destruction, fibrosis and thrombus formation.
Pathologic changes under the apical patch related to
defibrillation were observed in seven patients; two of
these had fewer than 5 defibrillations, one had 8 defi-
brillations and four had 21 to 74 defibrillations. These
changes consisted of contraction band necrosis in four
patients, vacuolar cytoplasmic clearing and loss of my-
ocytes confined to the myocardium under the patch elec-
trode in five patients who had multiple defibrillations.
The observed pathologic changes were estimated to af-
fect < 2% of the total myocardial mass. Thus, the au-
tomatic implantable cardioverter-defibrillator lead sys-
tem and multiple defibrillations result in localized
myocardial injury confined to the tissue under the patch
electrode. Superior vena cava lead-associated throm-
bosis may occur as with other long. term implanted trans-
venous catheters.
(J Am Coil CardioI1987;10:382-8)
with this device has been documented previously, infor-
mation regarding the pathologic consequences of the elec-
trode placement and the effect of repeated defibrillations in
humans has not been described in any appreciable number
of patients (2,3).
The effects of the leads and the consequences of repeated
defibrillations would be anticipated to produce the follow-
ing: I) direct effect of repeated discharges on the myocar-
dium and vascular structures, 2) possible thrombogenic po-
tential of the indwelling intravascular electrodes, and 3)
pericardial changes due to the pericardiotomy and placement
of the apical patch electrode intrapericardially. Previous
investigators (4,5) have pointed out that gross pathologic
changes can be observed in the myocardium directly under
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Table 1. Sudden Cardiac Death Survivor Population (February
I to November 30, 1985)
AICD = automatic implantable cardioverter-defibrillator; AID = au-
tomatic implantable defibrillator.
Results
Pathologic changes related to the apical patch elec-
trode (Fig. 1). Two patients died within 24 hours of the
placement of the apical patch electrode. Histologic changes
in these patients were limited to thin fibrin layer deposition
in the pericardial-epicardial interface. In two patients who
died after 24 hours but within 1 week of surgery (mean 6
days), early organizing pericarditis with infiltration of poly-
of the 56 patients was 56 ± 14 years (± SD); 21 were male
and 4 female. Twenty patients had coronary artery disease,
three had congestive cardiomyopathy, one had hypertrophic
cardiomyopathy and one had mitral valve prolapse. The
mean left ventricular ejection fraction was 32 ± 17%. This
group of patients, although highly selected, is representative
of the group as a whole in terms of both the etiology of the
underlying disease and other clinical variables, including
the age and the sex distribution.
Twelve patients (48%) died of incessant ventricular
tachycardia or ventricular fibrillation, and seven (28%) died
of left ventricular failure manifested by pulmonary edema
or cardiogenic shock. Six patients (24%) died of other causes:
one patient died secondary to a vascular tear and hemothorax
caused by insertion of a pulmonary artery catheter for in-
traoperative monitoring, two patients died secondary to sep-
sis, two patients had an introperative myocardial infarction
and could not be successfully weaned from cardiopulmonary
bypass and one patient had fulminant non-A, non-B hepatitis
that led to irreversible hepatic failure and death.
Pathology. All available pathologic materials were re-
viewed. The hearts of 15 patients were examined after post-
mortem angiography and fixation in distension (13). How-
ever, in all 25 patients histologic sections of the representative
sections of myocardium and pericardium were examined.
Additional histologic specimens were prepared to more clearly
document changes related to the placement of the electrodes
in the 15 available gross specimens. The amount of myo-
cardial tissue affected by defibrillation was visually esti-
mated from review of the whole heart and histologic spec-
imens.
24
19
II
8
Leads and Associated
Cardiac Surgery
(n = 43)
122
37
20
17
AID or AICD
(n = 159)
Alive
Dead
No autopsy
Autopsy
Methods
Study patients. A total of 159 survivors of sudden car-
diac arrest received an automatic defibrillator (either an AID
or an AICD model) between February 1980 and November
1985 at the Johns Hopkins and Sinai Hospitals, Baltimore,
Maryland. An additional 43 patients underwent only lead
implantation together with another cardiac surgical proce-
dure such as coronary bypass graft surgery, subendocardial
resection, aneurysmectomy, mitral valve replacement or
various combinations of these procedures in anticipation of
eventual generator placement. In most cases the leads were
placed at the time of surgery so that if the antiarrhythmic
drug therapy failed, the lead system, already in place, could
be easily connected to an automatic implantable cardio-
verter-defibrillator without an additional thoracotomy.
During this period, a total of 56 patients died, 37 with
an automatic implantable cardioverter-defibrillator and 19
with implanted leads only. Of the 25 patients in whom an
autopsy was performed, 17 had the automatic defibrillator
and 8 had implanted leads alone (Table 1). The mean age
the external defibrillator electrodes in dogs with higher lev-
els of direct current energy discharges. These changes are
related to the energy delivered, paddle size and the time
interval between discharges (6). The effects of repeated
internal defibrillator discharges on the myocardium in hu-
man subjects are unknown.
Thromboembolic complications have been described in
association with indwelling, permanent pacemaker leads
(7-9). Although the incidence of symptomatic thrombosis
is rare, the prevalence of asymptomatic partial or complete
obstruction in the superior vena cava is much more common
and occurs in a significant number of patients with in-
dwelling pacemaker leads (10,11). The larger size of the
superior vena cava lead used for the anode of the automatic
implantable cardioverter-defibrillator would be expected to
provide a more significant impedance to flow in the sub-
clavian vein and superior vena cava, possibly resulting in
a higher incidence of asymptomatic and symptomatic throm-
bosis.
The apical patch electrode, which functions as the cath-
ode of the defibrillating electrode pair, is most often placed
intrapericardially either at open thoracotomy, if additional
cardiac surgery is required, or from a subxiphoid incision
if the defibrillator is implanted (12). Pericarditis associated
with pericardiotomy and cardiac surgery is an expected
pathologic finding. However, additional changes that may
result from long-term implantation of the apical patch elec-
trode are unknown. The objective of the present study was
to examine retrospectively pathologic changes at autopsy
due to short-term and long-term electrode implantation and
multiple internal defibrillations in patients treated with the
automatic implantable cardioverter-defibrillator.
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Figure 1. Sequential postoperative
changes in the epicardial tissues be-
neath the patch in four patients at (A)
5 days. (B) 12 days. (C) 39 days and
(D) 696 days. The fibrin deposit pro-
gressively thickens, becomes orga-
nized and thins again in its mature col-
lagenized state. (Hematoxylin-eosin
stain; original magnification x 200:
reduced by 30%.)
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morphonuclear cell s and pericard ial to epicard ial adhesions
was seen . Five patients died within I month (mean 20 days)
of the apical patch placement. In these patients, organized
pericarditi s with round cell infiltrate was found.
Fifteen patients had an apical patch electrode present for
I month to 2 years (mean 392 days). These patients had
dense pericardial adhesions with an almost acellular con-
nective tissue layer. As the pericardial changes matured ,
the pericardium adjacent to the apical patch electrode under-
went remodeling with thinning and the eventual presence
of a gross leathery, shiny surface on inspection .
In one patient whose apical patch electrode was placed
extrapericardially, no pericarditis occurred. In the remaining
patients, who had an intrapericardial apical patch, clinical
manifestations of acute pericarditis were demonstrated post-
operatively. Howe ver , none had clinical evidence of peri-
cardial constriction.
Pitting or " thumbprints" are seen at the site of the patch
electrode due to the corrugation of the lead surface, which
helps to identify the pericardium as overlying the patch
electrode . The pericardial changes were localized to the
apical patch electrode (Fig. ID).
Pathologic changes related to the intravascular elec-
trodes (Table 2). Twenty-three of the 25 patients had the
spring-patch electrode configuration; in two patients the patch-
patch configuration was used because of high defibrillation
thresholds at the time of defibrillator implantation (>25 J).
In 4 (17%) of the 23 patients with a superior vena cava
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RV = right ventricle; SVC = superior vena cava.
Table 2. Pathologic Changes Associated With
Intravascular Electrodes
spring electrode, a large intravascular thrombus was asso-
ciated with the electrode. In two patients, multiple pul-
monary emboli were demonstrated at autopsy; in both pa-
tients, no emboli were clinically suspected. In one patient.
clinically recognized pulmonary emboli occurred with no
evidenceof an associated thrombus surrounding the superior
vena cava electrode. Only one patient had an associated
large thrombus in relation to the right ventricular (rate-
sensing) electrode, without pulmonary emboli demonstrated
at autopsy.
An electrical " bum" injury was noted in the superior
vena cava of a patient who had a total of 59 defibrillations
with the automatic implantablecardioverter-defibrillator. In
this patient, regional vein wall destruction with associated
thrombus was seen at autopsy (Fig. 2). The normal wall
architecture was replaced with fibrous tissue with an ad-
herent thrombus.
Pathologic changes related to the electrical injury (Ta-
ble 3, Fig. 3). In all eight patients who received implanted
SVC spring electrode
Large thrombus
Asymptomatic emboli
SVC thrombus associated
Not SVC thrombus associated
SVC " bum"
RV electrode (rate-sensing)
Large thrombus
No. of
Patients
4
2
leads only. no discernible histologic changes were seen in
the epicardiumor myocardium subjacent to the apical patch
electrode. In seven patients who received one defibrillation
during electrophysiologic testing but no additional defibril-
lations, no pathologic changes were observed. In two of
fi ve patients who received two to fi ve shocks (mean 3.8),
contraction band necrosisoccurred. In one patient witheight
defibrillations. vacuolar clearing changes were observed in
myocytes subjacent to the apical patch electrode with loss
of myocytes and fibrosis.
Four patients had 21 to 74 defibrillations (mean 45). In
patients whose defibrillatordischarged repeatedly within 24
hours of death, contraction band necrosis was observed sub-
jacent to the patch electrode. In four patients, cytoplasmic
vacuolar clearing was observed in the myocytes subjacent
to the apical patch electrode with diffuse myocyte loss and
fibrosis.
In the 15 hearts that were available for review, multiple
sections were obtained through both the subepicardial area
under the patch electrode and the unaffected myocardial
sections away from the electrode. In all hearts thus exam-
ined, the visual estimate of the tissue demonstrating the
pathologic changes did not exceed 2% of the left myocardial
mass.
Discussion
Pericardial changes related to the apical patch elec-
trode. Pericarditis is a nonspecific inflammatory response
to pericardiotomy either as a consequence of the cardiac
surgery or as a result of intrapericardial apical patch lead
insertion. In our series, all the patients, except the one who
had an extrapericardial lead, developed clinical manifesta-
.. ~
...
A
Figure 2. Superior vena cava changes .
A, Superior vena cava with obstruc-
tive organizing thrombus . B, Wall of
superior vena cava showing burn in-
jury at the luminal margin (top) and
inflammation and granulation tissue
replacing the vessel wall (below) (He-
matoxylin-eosin stain; original mag-
nifications: (A) x 10. (B) x 200: both
reduced by 30%.)
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Table3. Pathologic Changes Related to Electrical Injury Under the Apical Patch Electrode
Defibrillations Contraction Band Vacuolar
No. of No. < 24 Hours Necrosis Cytoplasmic Loss of
Patients Total No. Before Death (subepicardial) Clearing Myocytes
8 0 0 Absent Absent Absent
7 I 0 Absent Absent Absent
5 2 to 5 I 2 Absent Absent
I 8 0 Absent I I
4 21 to 74 4 2 4 4
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tions of acute pericarditis postoperatively, manifested by a
transient pericardial rub, fever and inspiratory pain. Those
changes generally resolved within 48 to 72 hours. They
were accompanied in some patients by echocardiographic
signs of pericardial effusion but without evidence of tam-
ponade. Pathologic changes varied from a thin fibrin layer
deposition in the pericardial-epicardial interface within 24
hours of pericardiotomy and lead placement to progressive
changes of organizing pericarditis. The early changes were
generalized, becoming localized to the apical patch elec-
trode and the surrounding tissue as the pericarditis matures.
Early polymorphonuclear leukocyte infiltrate, which was
seen in the first week, was replaced with a mononuclear
Figure 3. Myocardial changes beneath the patch in four patients .
A, Contraction bands in myocytes . B, Clearing of myocyte cy-
toplasm. C, Subepicardial zone of cleared myocytes. D, Subepi-
cardial replacement fibrosis. (Hematoxylin-eosin stain; original
magnifications: (A) and (B) x 500 (C) and (D) x 50; all reduced
by 25%.)
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cell infiltrate at about 1 week. The pericardial changes pro-
gressed to a dense, connective tissue layer that underwent
remodeling with disappearance of the cellular infiltrate and
further deposition of collagen. Eventually, in patients whose
apical patch electrode had been present for several months,
a thin, leathery adhesion of parietal pericardium, the elec-
trode and the visceral pericardium formed a compact, dense
layer (Fig. 1).
Thromboembolic complications related to the intra-
vascular leads. Thromboembolic phenomena have been
reported in association with permanent transvenous pacing
catheters in 0.6% of patients in one series (7) and 3 to 5%
of patients of another series (8). In a more recent study (9),
the incidence of asymptomatic pulmonary emboli, dem-
onstrated on routine radionuclide lung scanning 2 weeks
after pacemaker lead insertion, was 15%. The most common
factor predisposing to thromboembolic events was conges-
tive heart failure (10). The prevalence of this complication
may be grossly underestimated, however, as documented
by Stoney et a!. (11), who demonstrated total occlusion of
the deep venous system of the arm in 22% of 32 consecutive
patients studied by venography a mean of 18 months after
permanent pacemaker insertion. Severe, but partial obstruc-
tion with collateral circulation was noted in an additional
34%. Clinical signs suggesting thrombosis were unusual,
however.
In our series, the incidence of large venous thrombi con-
firmed at autopsy was relatively high (20%) as was the
incidence of asymptomatic emboli (8%). These findings at
autopsy, however, are not strictly comparable with the clin-
ical studies because most catheter-associated thrombi are
clinically silent, as the study of Stoney et a!. (1 I) suggests.
The possible sources of pulmonary emboli include calf or
leg veins, pelvic veins or intracardiac thrombi and the in-
travascular electrodes. Prolonged bed confinemant and im-
mobility predispose to formation of venous thrombi. Never-
theless, the thrombi associated with the superior vena cava
electrode cannot be excluded as a possible source of emboli
in at least two of our patients. The superior vena cava lead
has a larger profile (12F) and a larger surface area than those
of a conventional pacemaker lead. This could increase stasis
and thus predispose to thrombosis.
A possible alternative to using the superior vena cava
lead includes implantation of two electrode patches at the
time of surgery. This technique would offer an advantage
in patients undergoing thoracotomy for another reason, for
example, coronary artery bypass surgery, aneurysmectomy
or valve replacement. It is not known whether such an
approach would alter the morbidity of the procedure in pa-
tients who require only placement of an automatic implant-
able cardioverter-defibrillator. Thus, the possible risk of
thrombosis should be balanced against an additional risk of
thoracotomy in an otherwise compromised patient who typ-
ically has significant cardiac dysfunction.
Myocardial changes caused by electrical defibrilla-
tion. Effects of direct current cardioversion by external
paddles or direct cardiac application have been studied by
previous investigators. Transient elevations of cardiac crea-
tine kinase, MB fraction (MB CK) have been documented
(14). Warner et aI. (4) described gross and histologic changes
in 31 of 39 dogs that received 10 defibrillations with 400 J
of energy each to the chest wall using 8 cm electrodes and
in 12 dogs using 4 to 5 ern electrodes. The changes were
confined to the subepicardial area and consisted of necrosis
in the path of the current flow (between the paddles). Mi-
croscopic changes of increased granularity at 26 minutes,
loss of striations in the subepicardial muscle at 3 days and
fibrosis at 2 weeks were noted. Electron microscopy dem-
onstrated mitochondrial vacuolization, disarray and frag-
mentation of myofibrils and electron-dense bodies in the
degenerating mitochondria, thought to represent calcium
accumulation. The authors suggested a possible role of cal-
cium influx as the mechanism of the myocardial injury.
Van Vleet et a!. (5) studied 18 normal dogs in which
transthoracic shocks were delivered with a trapezoidal
waveform defibrillator. Eleven dogs given one to six shocks
at 1.2 to 1.9 A/kg per shock did not have cardiac changes
at autopsy performed 2 hours after shock delivery. Of seven
dogs given six suprathreshold shocks (3.2 to 10.6 A/kg),
one dog died and four were found to have myocardial le-
sions. These lesions were apparent on gross inspection and
consisted of discrete, pale areas located in the path of the
electrodes. Microscopic and ultrastructural studies revealed
I) damage to the mitrochondrial membranes and sarco-
plasmic reticulum, 2) intracellular edema and 3) contraction
band change and nuclear pyknosis (5).
The energy delivery by the automatic defibrillator is con-
siderably smaller than that used in the experimental animals
in the previously mentioned studies. However, some of the
histologic changes noted in the subepicardial layer subjacent
to the patch electrode have similarities to the changes seen
in the experimental animals in which cardioversion was
used. These changes were not present in patients who had
an apical patch lead and who received only a single internal
defibrillation during the electrophysiologic study (Table 2).
Thus, it is unlikely that the histologic changes observed in
the subepicardial layer are related to the lead itself. Fur-
thermore, the pathologic changes are the most marked in
those patients who received the greatest number of internal
defibrillations.
Causes of contraction band necrosis. Contraction band
necrosis confined to the myocardium beneath the patch elec-
trode was seen in patients who had internal defibrillations
within 24 hours of death, but did not occur in two such
patients and was also observed in one patient who had no
internal defibrillations 24 hours before death. Thus, it is
possible that this pathologic response may represent a non-
specific change related to a reflow injury (15). It is further
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possible to speculate that the individual susceptibility to
contraction band necrosis change is dependent on other local
factors, such as presence of ischemia, changes in pH, pres-
ence of free radicals or some other factor as yet undeter-
mined. Because the contraction band phenomenon was largely
confined to the area beneath the patch in those patients
receiving shocks in the immediate premortem interval «24
hours before death), it seems more probable that it was
secondary to electrical injury. Vacuolar cytoplasmic clear-
ing may be due to mitochondrial damage, similar to the
changes demonstrated by Warner (4) and Van Vleet (5) and
their coworkers in the experimental animals. This change
may lead to myocyte loss and subepicardial fibrosis.
Thus, the contraction band phenomenon may represent
an early response to electrical injury which, after repeated
defibrillations, may lead to cytoplasmic vacuolization and
eventual cell necrosis, followed by fibrosis. The myocardial
mass thus affected is small, and is estimated to be <2% of
the total myocardial mass. The physiologic effects of the
localized myocardial injury and fibrosis in the tissue sub-
jacent to the apical patch electrode are unknown. It is the-
oretically possible that focal myocyte loss and scarring may
lead to alteration in tissue properties and genesis of new
foci of reentry and new ventricular arrhythmias.
Electrical injury that resulted in vein wall destruction
was related to multiple defibrillations in one patient with
the superior vena cava lead. Fibrous tissue and thrombus
were present at the site of the wall injury, thus preventing
bleeding and exsanguination in this patient.
Limitations of the study. Many patients received mul-
tiple external defibrillations both before implantation of the
automatic implantable cardioverter-defibrillator and in the
immediate 24 hour period before death. The exact number
of external defibrillations is difficult to determine in anyone
patient because of incomplete documentation. However, the
effects of the external defibrillations would be expected to
produce generalized and random myocardial changes and
would not necessarily be confined to the myocardium under
the patch electrode. Thus, focal changes localized to the
subepicardial layer immediately under the patch electrode
are more likely to be the result of internal defibrillations
due to the automatic implantable cardioverter-defibrillator.
Conclusion. The present study demonstrated, first, that
pericarditis with focal changes related to the apical patch
electrode is a universal finding of little clinical consequence.
Early postoperative pericarditis results in progressive peri-
cardial organization and remodeling related to the apical
patch electrode. Constrictive pericarditis has not been dem-
onstrated in any of the patients.
Second, the presence of a superior vena cava lead was
associated with thrombi in 17% of the autopsy patients in
our series. A right ventricular rate-sensing electrode appears
to be less thrombogenic and was associated with thrombi
in only 4% of patients. Although asymptomatic emboli were
found in 8% of the autopsy patients, their possible origin
includes leg veins, mural thrombi as well as the implanted
leads. No patient died as a result of pulmonary emboli in
this series.
Finally, multiple defibrillations are associated with rec-
ognizable localized pathologic changes subjacent to the ap-
ical patch electrode. They consist of contraction band ne-
crosis, myocyte vacuolization and myocyte loss. These
changes involve a small segment of myocardium immedi-
ately subjacent to the apical patch electrode. Multiple de-
fibrillations may also occasionally produce vascular injury
related to the intravascular superior vena cava lead.
Thus, the automatic defibrillator device and its lead sys-
tem and multiple defibrillations lead to little myocardial or
pericardial injury. The electrophysiologic consequences re-
lated to the localized myocyte injury and fibrosis in this
group of patients are of unknown significance at present.
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